Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Research opens clever new way to attack cancer stem cells

Researchers are the University of Michigan Rogel Cancer are unraveling a crucial thread that explains why cancer so often becomes resistant to treatment.

3 Jul 2018

Sun avoidance may be almost as hazardous to health as cigarette smoking

Available on Amazon, Embrace the Sun, by authors Marc B. Sorenson, Ed.D.and William B. Grant, Ph.D.,claim that sun avoidance may be nearly as hazardous to your health as cigarette smoking!

3 Jul 2018

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today announced that U.S. researchers published scientific findings recommending development of anti-Liver Cancer Drugs based on a mechanism of action utilized by Namodenoson.

2 Jul 2018

Researchers discover gene that plays role in regulating body's immune response to infection

Australia's national science agency CSIRO has identified a new gene that plays a critical role in regulating the body's immune response to infection and disease.

2 Jul 2018

Study finds that several existing anti-cancer drugs may work in part by binding to RNA

Bolstering the notion that RNA should be considered an important drug-discovery target, scientists at Scripps Research have found that several existing, FDA-approved anti-cancer drugs may work, in part, by binding tightly to RNA, the regulators of the basic activities of life within cells.

30 Jun 2018

Top policy expert’s ties to giant drugmaker often go unstated

When Dr. Mark McClellan sat for an in-depth 30-minute question-and-answer session at an April health policy forum, the audience was filled with top researchers, advocates and Capitol Hill staffers eager to hear what insight the former head of the Food and Drug Administration would dispense.

29 Jun 2018

Pilates and yoga can benefit people of all ages and fitness levels

The idea of going for a run or joining a gym can be intimidating for people who don't exercise. When you have a health condition that prevents you from engaging in many types of high-impact exercise, it can also be tough to know where to start.

28 Jun 2018

New study finds way to help treat alcohol addiction and ease withdrawal symptoms

According to a new study by Scripps Research scientists, activating a receptor found in brain cells may help treat alcohol addiction and ease some withdrawal symptoms. The researchers studied the effects of activating the receptor in alcohol-addicted rats and reported the results today in the journal eNeuro.

27 Jun 2018

Researchers discover immune cells that create and sustain chronic inflammatory bowel disease

In preclinical experiments, Laurie Harrington, Ph.D., and colleagues at the University of Alabama at Birmingham have discovered a subset of immune cells that create and sustain chronic inflammatory bowel disease.

27 Jun 2018

Research provides new target to help treat chemotherapy-induced diarrhea

Some 50 to 80 percent of cancer patients taking powerful chemotherapy drugs develop diarrhea, which can be severe and in some cases life-threatening.

27 Jun 2018

A systematic approach towards diagnosis and treatment of rheumatoid arthritis

Rheumatoid Arthritis: A systematic approach (edited by Dr. Syuichi Koarada) comprehensively covers each aspect of the pathology, diagnosis and treatment of rheumatoid arthritis.

26 Jun 2018

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for standard review a new supplemental Biologics License Application for KEYTRUDA, Merck's anti-PD-1 therapy, as adjuvant therapy in the treatment of patients with resected, high-risk stage III melanoma and granted a Prescription Drug User Fee Act, or target action, date of February 16, 2019.

25 Jun 2018

Doling out pain pills post-surgery: An ingrown toenail not the same as a bypass

What's the right painkiller prescription to send home with a patient after gallbladder surgery or a cesarean section?

22 Jun 2018

Study provides clues to how cancer cells develop resistance to chemotherapies

About half of all drugs, ranging from morphine to penicillin, come from compounds that are from-;or have been derived from-;nature. This includes many cancer drugs, which are toxic enough to kill cancer cells.

22 Jun 2018

Scientists identify gene that triggers senescence

Scientists seeking to unlock the secrets of cellular aging have identified a gene that triggers senescence, a phenomenon in which cells stop dividing.

22 Jun 2018

Review: Stem cells appear to help fight obesity in animal models

Obesity is an increasing global health problem associated with several comorbidities and a high risk of mortality.

21 Jun 2018

Biosimilar competition may offer hope for cheaper, better psoriasis treatments in the future

A new study by iData Research estimates that there are nearly 150,000 new cases of psoriasis every year in the United States, affecting 2.2% of the population.

20 Jun 2018

Patients with mild Alzheimer's disease over age 65 continue to derive benefit from DBS-f treatment

An age group analysis of data from the ADvance trial has shown that participants over the age of 65 continue to derive the most benefit from Deep Brain Stimulation of the fornix, as observed in the data from the phase 2 findings (12 - 24 months) of the Phase II trial.

19 Jun 2018

SetPoint announces positive long-term results of bioelectronic medicine to treat rheumatoid arthritis

SetPoint Medical, a clinical-stage biomedical technology company developing bioelectronic therapy for chronic inflammatory diseases, announced positive long-term data for its first-in-human study using bioelectronic medicine for rheumatoid arthritis

19 Jun 2018

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today provided an update on its Phase II clinical trial with drug candidate Namodenoson in the treatment of advanced hepatocellular carcinoma in patients whose disease has progressed on sorafenib therapy.

19 Jun 2018

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Research opens clever new way to attack cancer stem cells

Sun avoidance may be almost as hazardous to health as cigarette smoking

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

Researchers discover gene that plays role in regulating body's immune response to infection

Study finds that several existing anti-cancer drugs may work in part by binding to RNA

Top policy expert’s ties to giant drugmaker often go unstated

Pilates and yoga can benefit people of all ages and fitness levels

New study finds way to help treat alcohol addiction and ease withdrawal symptoms

Researchers discover immune cells that create and sustain chronic inflammatory bowel disease

Research provides new target to help treat chemotherapy-induced diarrhea

A systematic approach towards diagnosis and treatment of rheumatoid arthritis

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Doling out pain pills post-surgery: An ingrown toenail not the same as a bypass

Study provides clues to how cancer cells develop resistance to chemotherapies

Scientists identify gene that triggers senescence

Review: Stem cells appear to help fight obesity in animal models

Biosimilar competition may offer hope for cheaper, better psoriasis treatments in the future

Patients with mild Alzheimer's disease over age 65 continue to derive benefit from DBS-f treatment

SetPoint announces positive long-term results of bioelectronic medicine to treat rheumatoid arthritis

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in